[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018,68(6):394-424.
[2] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J]. CA: a cancer journal for clinicians, 2016,66(2):115-132.
[3] Wang W, Chang J, Jia B, et al. The Blood Biomarkers of Thyroid Cancer[J]. Cancer Management and Research, 2020,Volume 12:5431-5438.
[4] Pitoia F, Smulever A. Active surveillance in low risk papillary thyroid carcinoma[J]. World J Clin Oncol, 2020,11(6):320-336.
[5] Houten R, Fleeman N, Kotas E, et al. A systematic review of health state utility values for thyroid cancer[J]. Qual Life Res, 2020.
[6] Zhao J Z, Tan X R, Zhao M, et al. Association between the X-ray repair cross-complementing group 1 Arg194Trp polymorphism and thyroid carcinoma susceptibility: A meta-analysis[J]. Genet Mol Res, 2016,15(3).
[7] Howlader N R, Rahman M M, Hossain M A, et al. Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population[J]. Breast Cancer Res Treat, 2020,182(3):739-750.
[8] Pasqualetti F, Gonnelli A, Orlandi P, et al. Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy[J]. Invest New Drugs, 2021.
[9] Shokofeh T, Shima F, Mina E, et al. Association of Thr241Met polymorphisms in XRCC3 gene and risk of differentiated thyroid carcinoma in Iran[J]. CLINICAL BIOCHEMISTRY, 2011,44S(13):S198-S199.
[10] Yu X, Liu H, Wang B, et al. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk[J]. TUMOR BIOLOGY, 2014,35(3):2009-2015.
[11] Lu W, Wu G, Zhang B. Association Between X-Ray Cross-Complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis[J]. MEDICAL SCIENCE MONITOR, 2015,21:3978-3985.
[12] Ni H, Bian JC, Shen Q et al: Genetic polymorphisms of XRCC3 and susceptibility of papillary thyroid carcinoma. Fudan Univ J Med Sci, 2006; 33: 147–52
[13] Akulevich N M, Saenko V A, Rogounovitch T I, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma[J]. ENDOCRINE-RELATED CANCER, 2009,16(2):491-503.
[14] Siraj A K, Al-Rasheed M, Ibrahim M, et al. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population[J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008,31(10):893-899.
[15] Wang X, Zhang K, Liu X, et al. Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015,8(3):3160-3167.
[16] Sturgis E M, Zhao C, Zheng R, et al. Radiation response genotype and risk of differentiated thyroid cancer: A case-control analysis[J]. LARYNGOSCOPE, 2005,115(6):938-945.
[17] Bastos H N, Antao M R, Silva S N, et al. Association of Polymorphisms in Genes of the Homologous Recombination DNA Repair Pathway and Thyroid Cancer Risk[J]. THYROID, 2009,19(10):1067-1076.
[18] Fayaz S, Karimmirza M, Tanhaei S, et al. Increased Risk of Differentiated Thyroid Carcinoma with Combined Effects of Homologous Recombination Repair Gene Polymorphisms in an Iranian Population[J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013,14(11):6727-6731.
[19] Yuan K, Huo M, Sun Y, et al. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population[J]. TUMOR BIOLOGY, 2016,37(1):979-987.
[20] Sarwar R, Mahjabeen I, Bashir K, et al. Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer[J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017,42(1):22-33.
[21] Yan L, Li Q, Li X, et al. Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma[J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016,38(3):1075-1084.
[22] Santos L S, Gomes B C, Bastos H N, et al. Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes[J]. GENES, 2019,10(5868).
[23] Sangrajrang S, Schmezer P, Burkholder I, et al. The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population[J]. Biomarkers, 2007,12(5):523-532.
[24] Talar-Wojnarowska R, Gąsiorowska A, Olakowski M, et al. Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer[J]. Biomed Rep, 2016,4(2):236-240.
[25] Kaur J, Sambyal V, Guleria K, et al. Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk[J]. Clin Exp Gastroenterol, 2020,13:73-86.
[26] He Y, Penney M E, Negandhi A A, et al. XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer[J]. PLoS One, 2018,13(2):e192316.
[27] Jacobsen N R, Raaschou-Nielsen O, Nexø B, et al. XRCC3 polymorphisms and risk of lung cancer[J]. Cancer Lett, 2004,213(1):67-72.
[28] Alkasaby M K, Abd E A, Ibrahim I H, et al. Polymorphism of XRCC3 in Egyptian Breast Cancer Patients[J]. Pharmgenomics Pers Med, 2020,13:273-282.
[29] Aboul E A, Khaled I, Khorshied M M, et al. Genetic variations in DNA-repair genes (XRCC1, 3, and 7) and the susceptibility to hepatocellular carcinoma in a cohort of Egyptians[J]. J Med Virol, 2020.
[30] León-Mejía G, Quintana-Sosa M, de Moya H Y, et al. DNA repair and metabolic gene polymorphisms affect genetic damage due to diesel engine exhaust exposure[J]. Environ Sci Pollut Res Int, 2020,27(16):20516-20526.
[31] Su Y, Zhang H, Xu F, et al. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival[J]. Cell Physiol Biochem, 2015,36(4):1419-1429.
[32] Chai F, Liang Y, Chen L, et al. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies[J]. Med Sci Monit, 2015,21:3231-3240.
[33] Su C H, Chang W S, Hu P S, et al. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk[J]. Cancer Genomics Proteomics, 2015,12(6):359-367.
[34] Chen H J, Chang W S, Hsia T C, et al. Contribution of Genotype of DNA Double-strand Break Repair Gene XRCC3, Gender, and Smoking Behavior to Lung Cancer Risk in Taiwan[J]. Anticancer Res, 2015,35(7):3893-3899.
[35] Guo J, Lv H C, Shi R H, et al. Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population[J]. Genet Mol Res, 2015,14(4):16484-16490.
[36] Fan J, Fan Y, Kang X, et al. XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis[J]. Oncol Lett, 2015,9(5):2425-2429.
[37] Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk[J]. TUMOR BIOLOGY, 2014,35(5):4791-4797.
[38] Soliman A, Zaki N N, Fathy H M, et al. Genetic polymorphisms in XRCC1, OGG1, and XRCC3 DNA repair genes and DNA damage in radiotherapy workers[J]. Environ Sci Pollut Res Int, 2020,27(35):43786-43799.